Tirzepatide is a next-generation peptide medication that mimics both GLP-1 and GIP hormonestwo key regulators of blood sugar control and appetite signaling
Complete your virtual consultation 15-minute video call
Those with Chronic Illnesses or High Toxin Exposure People exposed to environmental toxins, such as pollution or chemicals, may benefit from Glutathione IV Drip
24 A short-term, double-blind clinical study involving 426 patients with peripheral neuropathy of different etiologies, showed statistically meaningful differences between the ALC and placebo groups in terms of mean conduction velocity improvement
The proportions of patients with SALT 20 or 10 at week 48 ranged from 20% to 50% in the 30mg ritlecitinib groups (Table 1).8 Among adolescents with AT or AU, 13% (1/8), 25% (2/8), 50% (4/8), and 0% (0/8) achieved SALT 20 at week 48 in the ritlecitinib 200/50mg, 200/30mg, 50mg, and 30mg groups, respectively
No Therapeutic Use Exemption pathway exists for BPC-157 because the compound has no approved therapeutic indication in any major jurisdiction worldwide